Insights & Analysis

Industry insights that are curated and delivered to inform your dealmaking strategies. We select the most relevant information, providing a consistent, convenient source for exclusive intelligence and analysis.

All News Activism M&A Podcasts Private Cos. Private Equity Restructuring Scoops & Exclusives SPACs

Page 74

M&A

Pfizer's Lankler Confirmed for Deal Economy Conference

By Armie Margaret Lee
|
Published: November 14th, 2019
On the heels of Pfizer's purchase of Array BioPharma and Therachon and its deal to combine its Upjohn unit with Mylan, the New York biopharmaceutical giant's general counsel is slated to speak at The Deal Economy Conference in New York on Nov. 20.
Podcasts

Drinks With The Deal: PJ Solomon’s Marc Cooper

By David Marcus
|
Published: November 13th, 2019
The investment banker and retail specialist chats with The Deal's David Marcus about brand authenticity, the challenges of being a CEO and the joys of the half-bottle.
Activism

Activist Investing Today: SMU's Goodwin on CEO Lobbying Group

By Ronald Orol
|
Published: November 13th, 2019
Shane Goodwin, the chief of the Applied Corporate Governance Institute, says Milton Friedman’s 1970 doctrine of shareholder primacy is misunderstood and that the Business Roundtable’s recent ‘stakeholders’ statement of purpose may have a hard time withstanding the next recession.
Podcasts

Activist Investing Today: Columbia's Coffee on Activists, M&A and Rules

By Ronald Orol
|
Published: November 13th, 2019
Columbia Law School Professor John Coffee spoke with The Deal for its Activist Investing Today podcast about Carl Icahn's Occidental Petroleum campaign, M&A, activism's impact on R&D budgets and potential new for influential proxy advisers.
 
Solutions
Contact The Deal
Tel:
1-888-667-3325
International:
+1-212-224-3069
Email:
customerservice@thedeal.com
© 2024 The Deal.

Part of the Delinian Group. Terms of Use, Commercial Terms & Conditions, Privacy Policy, Accessibility, Modern Slavery Act